The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Syngenta AG

NYSE: SYT
Last

(U.S.) $85.93

Today's change+1.49 +1.76%
Updated January 20 4:02 PM EST. Delayed by at least 15 minutes.
 

Syngenta AG

NYSE: SYT
Last

(U.S.) $85.93

Today's change+1.49 +1.76%
Updated January 20 4:02 PM EST. Delayed by at least 15 minutes.

Syngenta AG Hits New 50-day High

Syngenta AG closed up sharply Friday, rallying (U.S.)$1.49 or 1.76% to (U.S.)$85.93 and setting a new 50-day high. Over the last five days, shares have gained 3.98% and are currently 3.59% off of the 52-week high. Over the last year, this stock has performed in-line with the S&P 500, gaining 20.81%.

Key company metrics

  • Open(U.S.) $85.54
  • Previous close(U.S.) $84.44
  • High(U.S.) $86.24
  • Low(U.S.) $85.40
  • Bid / Ask-- / --
  • YTD % change+8.70%
  • Volume1,026,290
  • Average volume (10-day)712,538
  • Average volume (1-month)626,447
  • Average volume (3-month)776,637
  • 52-week range(U.S.) $68.94 to (U.S.) $89.13
  • Beta1.05
  • Trailing P/E33.42×
  • P/E 1 year forward25.27×
  • Forward PEG3.37×
  • Indicated annual dividend(U.S.) $2.29
  • Dividend yield2.67%
  • Trailing EPS(U.S.) $2.57
Updated January 20 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.21%

Based on its net profit margin of 9.21%, Syngenta AG is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.90%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q4/2015Q2/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Dec 31, 201512/31/2015Jun 30, 201506/30/2015Dec 31, 201412/31/2014
Revenue7,0945,7777,6346,626
Total other revenue--------
Total revenue7,0945,7777,6346,626
Gross profit3,5252,5983,7712,911
Total cost of revenue3,5693,1793,8633,715
Total operating expense5,7435,5026,0686,246
Selling / general / administrative1,3501,4201,3791,652
Research & development652674688708
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)145222166147
Other operating expenses, total--------
Operating income1,3512751,566380
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1,2261221,470261
Income after tax1,0661201,224228
Income tax, total160224633
Net income1,0641181,221228
Total adjustments to net income--------
Net income before extra. items1,0641181,221228
Minority interest-2-2-30
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,0641181,221228
Inc. avail. to common incl. extra. items1,0641181,221228
Diluted net income1,0641181,221228
Dilution adjustment------0
Diluted weighted average shares92929292
Diluted EPS excluding extraordinary itemsvalue per share11.581.2813.252.48
Dividends per sharevalue per share0.0011.250.0011.07
Diluted normalized EPSvalue per share13.624.2915.392.78